Brachytherapy for Prostatic Carcinoma Patients | MicrobiomeTrials← Back to trialsNCT00525720
Brachytherapy for Prostatic Carcinoma Patients
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2006-08-01Est. Completion: 2027-09-30
Enrollment target: 300 participants Locations- University of Texas MD Anderson Cancer Center, Houston, Texas, United States
Other microbiome trials you might be interested in
Prostate CancerRecurrent Prostate CancerMetastatic Prostate CancerProstate Cancer RecurrentProstate Cancer Metastatic
This is a randomized, open-label, pilot study assessing the impact of a short course of bicalutamide on PSMA expression …
St Louis, United StatesEst. completion Nov 14, 2027
Prostate Cancer
Prostate cancer is the most frequently diagnosed cancer among men over 50 years old in Western societies, with an incide…
Hackensack, United StatesCompleted Oct 1, 2026
Recurrent Prostate CancerProstate Cancer
Background:
Biochemically recurrent prostate cancer (BCR) occurs when prostate-specific antigen (PSA) levels in the blo…
Bethesda, United StatesEst. completion Jan 30, 2029